Stock AGIO AGIOS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Agios Pharmaceuticals, Inc.

Equities

AGIO

US00847X1046

Real-time Estimate Cboe BZX
Other stock markets
 03:02:27 2024-05-21 pm EDT 		5-day change 1st Jan Change
34.18 USD +3.00% Intraday chart for Agios Pharmaceuticals, Inc. -0.35% +52.76%
May. 16 Transcript : Agios Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08:40 AM
May. 02 Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Agios Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08:40 AM
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
AQ
Agios Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
AQ
Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024
AQ
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
AQ
Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss
MT
Agios Pharmaceuticals : First Quarter 2024 Financial Results Presentation
PU
Transcript : Agios Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024
Agios Pharmaceuticals: Q1 Earnings Snapshot
AQ
Earnings Flash (AGIO) AGIOS PHARMACEUTICALS Reports Q1 Revenue $8.2M
MT
Agios Reports Business Highlights and First Quarter 2024 Financial Results
AQ
Agios Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
AQ
Agios Publishes 2024 Environmental, Social and Governance Report
AQ
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
AQ
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
AQ
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
AQ
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
AQ
RBC Trims Price Target on Agios Pharmaceuticals to $42 From $43, Keeps Outperform Rating
MT
Agios Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AGIO Stock
  4. News Agios Pharmaceuticals, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW